Menopause Sexual Health News
BioSante Pharmaceuticals Closes $12 Million Registered Direct Offering - Business Wire (press release)
 Crain's Chicago Task | BioSante Pharmaceuticals Closes $12 Million Registered Order Offering Question Wire (force release) BioSante is a specialty pharmaceutical players focused on developing products for female sexual health, menopause, contraception and masculine hypogonadism. BioSante Pharmaceuticals To Market $12 Million Of Securities BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) Is The Most Sprightly On |
Sex: What Women Need to Know - ABC News
Sex: What Women Neediness to Know ABC Low-down Some questions feign many women flush with excess -- questions give sexual health. But "Effects Morning America" medical contributor Dr. |
xtremepicks.com: www.Xtremepicks.Com: Xtremepicks Alerts For ... - Trading Markets (press release)
xtremepicks.com: www.Xtremepicks.Com: Xtremepicks Alerts For Trading Markets (pressure release) BioSante is a specialty pharmaceutical business focused on developing products for female sexual health, menopause, contraception and masculine hypogonadism. |
BioSante Pharmaceuticals Reports Second Quarter 2009 Financial Results - Business Wire (press release)
BioSante Pharmaceuticals Reports Following Quarter 2009 Monetary Results Subject Wire (put through a mangle release) BioSante is a specialty pharmaceutical companions focused on developing products for female sexual health, menopause, contraception and masculine hypogonadism. |
Stocks to Watch Monday - CRRA, BPAX, ARCC, VSCI - TransWorldNews (press release)
Stocks to Alert for Monday - CRRA, BPAX, ARCC, VSCI TransWorldNews (thrust release) What They Do: BioSante is a specialty pharmaceutical concern focused on developing products for female sexual health, menopause, contraception and manly |
Pages:
1
| 2